Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer
Samarth Hegde, Varintra E. Krisnawan, Brett H. Herzog, et al.
Cancer Cell (2020) Vol. 37, Iss. 3, pp. 289-307.e9
Open Access | Times Cited: 362

Showing 1-25 of 362 citing articles:

Pancreatic cancer: Advances and challenges
Christopher J. Halbrook, Costas A. Lyssiotis, Marina Pasca di Magliano, et al.
Cell (2023) Vol. 186, Iss. 8, pp. 1729-1754
Open Access | Times Cited: 554
Challenges and Opportunities for Pancreatic Cancer Immunotherapy
Adham S. Bear, Robert H. Vonderheide, Mark H. O’Hara
Cancer Cell (2020) Vol. 38, Iss. 6, pp. 788-802
Open Access | Times Cited: 443
Dendritic Cells and Their Role in Immunotherapy
Alycia Gardner, Álvaro de Mingo Pulido, Brian Ruffell
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 395
Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer
Nina G. Steele, Eileen S. Carpenter, Samantha B. Kemp, et al.
Nature Cancer (2020) Vol. 1, Iss. 11, pp. 1097-1112
Open Access | Times Cited: 359
Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma
Yunzhen Qian, Yitao Gong, Zhiyao Fan, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 250
Cell death in pancreatic cancer: from pathogenesis to therapy
Xin Chen, Herbert J. Zeh, Rui Kang, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 11, pp. 804-823
Closed Access | Times Cited: 242
A reservoir of stem-like CD8 + T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response
Kelli A. Connolly, Manik Kuchroo, Aarthi Venkat, et al.
Science Immunology (2021) Vol. 6, Iss. 64
Open Access | Times Cited: 241
The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives
Shun Wang, Yan Zheng, Yang Feng, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 237
Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance
Mara H. Sherman, Gregory L. Beatty
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 123-148
Open Access | Times Cited: 206
Tumor-infiltrating dendritic cell states are conserved across solid human cancers
Genevieve M. Gerhard, Ruben Bill, Marius Messemaker, et al.
The Journal of Experimental Medicine (2020) Vol. 218, Iss. 1
Open Access | Times Cited: 190
The CD155/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer
William A. Freed-Pastor, Laurens J. Lambert, Zackery A. Ely, et al.
Cancer Cell (2021) Vol. 39, Iss. 10, pp. 1342-1360.e14
Open Access | Times Cited: 188
Translational advances in pancreatic ductal adenocarcinoma therapy
Abdel Hosein, Stephanie K. Dougan, Andrew J. Aguirre, et al.
Nature Cancer (2022) Vol. 3, Iss. 3, pp. 272-286
Open Access | Times Cited: 176
The role of dendritic cells in cancer and anti-tumor immunity
Ariel E. Marciscano, Niroshana Anandasabapathy
Seminars in Immunology (2021) Vol. 52, pp. 101481-101481
Open Access | Times Cited: 170
Regulation and modulation of antitumor immunity in pancreatic cancer
Joshua Leinwand, George Miller
Nature Immunology (2020) Vol. 21, Iss. 10, pp. 1152-1159
Closed Access | Times Cited: 167
Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis
Jeffrey H. Lin, Austin P. Huffman, Max M. Wattenberg, et al.
The Journal of Experimental Medicine (2020) Vol. 217, Iss. 8
Open Access | Times Cited: 152
Targeting the CCL2/CCR2 Axis in Cancer Immunotherapy: One Stone, Three Birds?
Liyang Fei, Xiaochen Ren, Haijia Yu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 148
Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer
Daniel Cui Zhou, Reyka G. Jayasinghe, Siqi Chen, et al.
Nature Genetics (2022) Vol. 54, Iss. 9, pp. 1390-1405
Open Access | Times Cited: 136
Therapeutic developments in pancreatic cancer
Zilun Hu, Eileen M. O’Reilly
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 21, Iss. 1, pp. 7-24
Closed Access | Times Cited: 135
Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer
Katelyn T. Byrne, Courtney B. Betts, Rosemarie Mick, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 16, pp. 4574-4586
Open Access | Times Cited: 129
Tumor Burden and Immunotherapy: Impact on Immune Infiltration and Therapeutic Outcomes
Samuel I. Kim, Christopher R. Cassella, Katelyn T. Byrne
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 123
Innate Immunity and Cancer Pathophysiology
Laura Maiorino, Juliane Daßler‐Plenker, Lijuan Sun, et al.
Annual Review of Pathology Mechanisms of Disease (2021) Vol. 17, Iss. 1, pp. 425-457
Open Access | Times Cited: 107
Dendritic cells as orchestrators of anticancer immunity and immunotherapy
Ignacio Heras‐Murillo, Irene Adán‐Barrientos, Miguel Á. Galán, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 257-277
Closed Access | Times Cited: 105
Dendritic cells as shepherds of T cell immunity in cancer
Mikaël J. Pittet, Mauro Di Pilato, Christopher Garris, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2218-2230
Open Access | Times Cited: 92
Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy
Zaoqu Liu, Zhaokai Zhou, Qin Dang, et al.
Theranostics (2022) Vol. 12, Iss. 14, pp. 6273-6290
Open Access | Times Cited: 86
Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 84
Page 1 - Next Page

Scroll to top